Decreased glucagon-like peptide 1 release after weight loss in overweight/obese subjects (Q46493618)

22 December 2017

title

Decreased glucagon-like peptide 1 release after weight loss in overweight/obese subjects (English)

1 reference

22 December 2017

Margriet S Westerterp-Plantenga

main subject

obesity

0 references

author

series ordinal

3

object named as

Margriet S Westerterp-Plantenga

1 reference

22 December 2017

author name string

Tanja C M Adam

series ordinal

1

1 reference

22 December 2017

Johan Jocken

series ordinal

2

1 reference

22 December 2017

publication date

1 April 2005

1 reference

22 December 2017

published in

Obesity

1 reference

22 December 2017

volume

13

1 reference

22 December 2017

issue

4

1 reference

22 December 2017

page(s)

710-716

1 reference

22 December 2017

Preventing cardiovascular disease in diabetes and glucose intolerance: evidence and implications for care

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

Obesity as a cardiovascular risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

Analysis of energy density of food in relation to energy intake regulation in human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

Mechanisms of appetite control and their abnormalities in obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

Attenuated GLP-1 secretion in obesity: cause or consequence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

Inhibition of carbohydrate-mediated glucagon-like peptide-1 (7-36)amide secretion by circulating non-esterified fatty acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

Gastric pacing for morbid obesity: plasma levels of gastrointestinal peptides and leptin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

Orlistat augments postprandial increases in glucagon-like peptide 1 in obese type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

The reproducibility of subjective appetite scores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

Deuterium dilution as a method for determining total body water: effect of test protocol and sampling time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

The gross composition of the body

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

Insulinotropic action of glucagonlike peptide-I-(7-37) in diabetic and nondiabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

The effect of circulating non-esterified fatty acids on the entero-insular axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

Cardiac parasympathetic activity is increased by weight loss in healthy obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

Comparisons of leptin, incretins and body composition in obese and lean patients with hypopituitarism and healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

Obesity and disease management: effects of weight loss on comorbid conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

Pattern and intensity of physical activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

Glucagonlike peptide 1: a newly discovered gastrointestinal hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

Total body water measurement in humans with 18O and 2H labeled water

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

A dual-respiration chamber system with automated calibration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

High protein intake sustains weight maintenance after body weight loss in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

Effect of leptin on hypothalamic GLP-1 peptide and brain-stem pre-proglucagon mRNA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

Whole-body fat oxidation rate and plasma triacylglycerol concentrations in men consuming an ad libitum high-carbohydrate or low-carbohydrate diet.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.80

31 March 2020

Identifiers

DOI

10.1038/OBY.2005.80

1 reference

22 December 2017

PubMed ID

15897480

1 reference

22 December 2017